Richard J. Powell

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Michael S. Conte, Andrew W. Bradbury, Philippe Kolh et al. · European Journal of Vascular and Endovascular Surgery · 2019 · 1.5K citations · Full text

Medicine, Perioperative Medicine, Surgery +14

Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes

Michael McDermott, Ivona Aksentijevich, Jérôme Galon et al. · Cell · 1999 · 1.4K citations · Full text

Medicine, Genetics, Molecular Genetics +17

Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia

Alik Farber, Matthew T. Menard, Michael S. Conte et al. · New England Journal of Medicine · 2022 · 820 citations · Full text

Medicine, Orthopedic Surgery, Surgery +15

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15